Src, Yes, Fyn, and Fgr make up the SrcA subfamily, while Lck, Hck, Blk, and Lyn belong to the SrcB subfamily, and Frk has its own subfamily. The Src family kinase (SFK) family of non-receptor tyrosine kinases has nine members in total. Src-family kinases (SFKs) have been identified as important immune cell regulators of numerous intracellular signaling pathways.Src-family kinases (SFKs) participate in a number of signaling transduction cascades, including those originating from integrins, growth factor receptors, T and B cell antigen receptors, and Fc receptors. Src-family kinases (SFKs) can play both positive and negative regulatory roles in cellular signaling.By phosphorylating immunoreceptor tyrosine-based inhibitory motifs (ITIMs) on inhibitory receptors, they can attract and activate inhibitory molecules like the phosphatases SHP-1 and SH2 containing 5′ inositol phosphatase (SHIP-1) and act as negative regulators of cellular signaling.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V88068 | (R)-LW-Srci-8 | (R)-LW-Srci-8 is a selective covalent inhibitor of c-Src (IC50= 35.83 nM), which can impair the autophosphorylation of c-Src by targeting the autophosphorylation site (Y419) of c-Src kinase. | |
|
V119770 | AG01 | AG01 is a monoclonal antibody targeting the granule protein precursor (GP88). | |
|
V88070 | Cisplatin/Dasatinib prodrug-1 | Cisplatin/Dasatinib prodrug-1 (Compound 3) is a prodrug of Cisplatin and Dasatinib. | |
|
V88069 | CSK substrate | CSK substrate is a specific substrate of C-terminal Src kinase (CSK), which can bind to CSK and downregulate the levels of Src family members. | |
|
V108919 | DFCI-002-06 | 3092208-36-8 | DFCI-002-06 is an orally effective dual-target HCK/BTK protein degrader with DC₅₀ values of 1.3 nM for HCK and 4.5 nM for BTK. |
|
V97116 | FAK inhibitor 7 | 2890814-94-3 | FAK inhibitor 7 is a FAK inhibitor with IC50 of 3.58 nM. |
|
V113526 | FITC-amide-C2 Lck inhibitor 2 | 1338346-32-9 | FITC-amide-C2 Lck inhibitor 2 is a FITC-labeled Lck inhibitor. |
|
V119000 | FRK Recombinant Human Active Protein Kinase | FRK recombinant human active protein kinase is a non-receptor tyrosine kinase belonging to the Fyn-associated kinase family and is a member of the BRK kinase family (BFK). | |
|
V118909 | FYN Y531F Recombinant Human Active Protein Kinase | FYN Y531F recombinant human active protein kinase is an oncogene that directly activates YANK2 by phosphorylation of the Y110 site. | |
|
V109918 | Fyn-IN-1 | 3107638-80-9 | Fyn-IN-1 (compound 43) is a selective blood-brain barrier penetration inhibitor that inhibits Fyn and GSK-3β, with IC50 values of 0.044 μM and 0.61 μM, respectively. |
|
V116671 | Hck-IN-3 | Hck-IN-3 (compound 2D) is an orally effective HCK inhibitor (KD = 3.92 μM). | |
|
V107826 | ISO24 | 473707-40-3 | ISO24 (compound 4a) is a potent ligand for Src SH2 with an IC50 of 4.4 mM in BIAcore analysis. |
|
V87990 | KIN-8194 | 330786-01-1 | KIN-8194 is an orally active dual inhibitor of HCK and BTK with IC50 values of 0.915 and 0.495 nM, respectively. |
|
V109967 | LCK degrader-3 | 3095032-59-7 | LCK Degrader-3 (Compound 20) is a CRBN-based LCK molecular glue degrader. |
|
V83632 | Lck-IN-2 | 2615173-24-3 | |
|
V117716 | Lck-IN-4 | 1326278-38-9 | Lck-IN-4 (compound A-1) is a protein tyrosine kinase Lck inhibitor with an IC50 value of 2 nM. |
|
V109920 | Lck-IN-5 | 1356734-45-6 | Lck-IN-5 (e.g., C10) is a potent and selective inhibitor of lymphocyte-specific protein tyrosine kinases (LCK). |
|
V117028 | Papaveroline | 574-77-6 | Papaverine is an inhibitor of Fyn tyrosine kinase. |
|
V88074 | pFYN peptide | pFYN peptide is a biotinylated, phosphorylated peptide substrate derived from FYN (Src family kinase). | |
|
V0668 | PP1 | 172889-26-8 | PP1 (known also as EI275; EI-275; PP-1; PP 1; AG1872; AG-1872) is a novel, potent and selective Src kinase inhibitor with potential antitumor activity. |